Opinions Stockchase Discover
Atossa TherapeuticsATOSBUYJul 13, 2021
Allan Tong’s Discover Picks Two analysts rate ATOS stock a buy with a price target of $7.50 or 41% upside. Again, this is purely a speculative play and a volatile one with a 2.21 beta though it is a recovery stock. Fundamentals are spotty with insufficient data on Atossa’s margins and price earnings, so you’re betting on AT-H201, much like the market was wagering on who would win the vaccine sweepstakes 16 months ago. Read 3 Post-Covid Recovery Stocks to Buy for our full analysis.
Stockchase DiscoverOwned
$6.35
Stock price when the opinion was issued
$5.23
As of May 29, 2026. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
